Epilepsy is the most common neurological disorder, with the World Health Organization estimating prevalence at around 1% of the global population¹. For almost a century, the ketogenic diet has been used for the management of drug resistant epilepsy. Although the diet was a preferred option in the management of epilepsy until the 1920s, its use declined after the introduction of anti-epileptic drugs. The recognition that the ketogenic diet is a valid option for difficult-to-treat epilepsy, has led to a renewed interest since the 1990s.